Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases
- Status
- UNKNOWN
- Phase
- NA
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
- Status
- RECRUITING
- Phase
- N/A
Multicenter, Prospective, Real World Study of Camrelizumab in Cross-line Treatment of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study of Oral MRT-2359 in Selected Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
- Status
- UNKNOWN
- Phase
- NA
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
- Status
- COMPLETED
- Phase
- PHASE2
Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy
- Status
- RECRUITING
- Phase
- N/A
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Study to Evaluate D-1553 in Subjects With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2